Status
Conditions
About
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Aygin Ekincioglu, Prof.Dr. -Head of department; İzgi BAYRAKTAR, PhD (c)- Lecturer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal